9614 Federal Register / Vol. 75, No. 41 / Wednesday, March 3, 2010 / Notices 

Dated: February 24, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–4440 Filed 3–2–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated October 16, 2009, and 

published in the Federal Register on 

October 28, 2009 (74 FR 55584), Clinical 

Supplies Management, 342 42nd Street 

South, Fargo, North Dakota 58103, made 

application to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of Poppy Straw Concentrate 

(9670), a basic class of controlled 

substance listed in schedule II. 

The company plans to import an 

ointment for the treatment of wounds 

which contains trace amounts of 

controlled substances normally found in 

poppy straw concentrate which will be 

packaged and labeled for clinical trials. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and § 952(a), 

and determined that the registration of 

Clinical Supplies Management to import 

the basic class of controlled substance is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated Clinical 

Supplies Management to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and § 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: February 24, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–4439 Filed 3–2–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated October 30, 2009, and 

published in the Federal Register on 

November 6, 2009, (74 FR 57522), ISP 

Freetown Fine Chemicals, 238 South 

Main Street, Assonet, Massachusetts 

02702, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

2,5–Dimethoxyamphetamine 

(7396) ........................................ I 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Phenylacetone (8501) .................. II 

Dextropropoxyphene, bulk (nondosage forms) (9273) ............... II 

The company plans to manufacture 

bulk API, for distribution to its 

customers. The bulk 2,5– 

Dimethoxyamphetamine will be used 

for conversion into non-controlled 

substances. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 USC 823(a) and determined 

that the registration of ISP Freetown 

Fine Chemicals to manufacture the 

listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated ISP Freetown Fine 

Chemicals to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 USC 823, and 

in accordance with 21 CFR 1301.33, the 

above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: February 25, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–4400 Filed 3–2–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated October 16, 2009, and 

published in the Federal Register on 

October 28, 2009, (74 FR 55587), 

Cayman Chemical Company, 1180 East 

Ellsworth Road, Ann Arbor, Michigan 

48108, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in schedule 

I: 

Drug Schedule 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ...... I 

The company plans to manufacture 

small quantities of marihuana 

derivatives for research purposes. 

In reference to drug code 7360 

(Marihuana), the company plans to bulk 

manufacture cannabidiol. In reference to 

drug code 7370 

(Tetrahydrocannabinols), the company 

will manufacture a synthetic THC. No 

other activity for this drug code is 

authorized for this registration. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Cayman Chemical Company to 

manufacture the listed basic classes of 

controlled substances is consistent with 

the public interest at this time. DEA has 

investigated Cayman Chemical 

Company to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: February 24, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–4401 Filed 3–2–10; 8:45 am] 

BILLING CODE 4410–09–P 

mstockstill on DSKH9S0YB1PROD with NOTICES